Researchers are studying GLP-1 receptor agonists for potential roles in treating alcohol use disorder, nicotine addiction, and other compulsive behaviors, though this research is still ongoing
There is also a cardiac hybrid OR that brings a catheterization lab and surgery suite together in one space, making aortic aneurysm treatment more efficient and encouraging collaboration between our expert providers
Untreated obesity is linked to a number of serious health conditions, including: Cardiovascular disease: Obesity increases the risk of high blood pressure, heart attacks, and strokes
Sleep quality may improve as weight decreases and sleep apnea symptoms lessen
As with other GLP-1 receptor agonists, liraglutide stimulates insulin secretion and reduces glucagon secretion in a glucose-dependent manner
Multiple randomized controlled trials confirm GLP-1 receptor agonists produce sustained weight loss of 1522% over 68 weeks, with improved cardiovascular outcomes and reduced type 2 diabetes risk
